Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 36,004 | N/A |
| Other current assets | 2,040 | 0 |
| TOTAL | $38,044 | $N/A |
| Non-Current Assets | ||
| Other Non-Current Assets | 133 | 0 |
| TOTAL | $133 | $N/A |
| Total Assets | $38,177 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,477 | 0 |
| Accrued Expenses | 723 | N/A |
| TOTAL | $3,200 | $N/A |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $3,200 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 1 | N/A |
| Retained earnings | -71,133 | N/A |
| Other shareholders' equity | 77,192 | 0 |
| TOTAL | $34,977 | $N/A |
| Total Liabilities And Equity | $38,177 | $0 |